Boryung is a pharmaceutical company based in South Korea that develops and manufactures pharmaceutical products.

Boryung

(주)보령

IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

SSL by Default

Apple Mobile Web Clips Icon

Mobile Non Scaleable Content

nginx

DMARC

Apache

Senior Director of Healthcare Marketing

Jaerang Seong

Project Manager

sunhye Im

Jay Jung Gyun Kim

Pharmaceutical Acquired Companies With Fewer Than 1000 Employees

Biotechnology Companies With Fewer Than 10 Employees (Top 10K)

Seoul Companies With Fewer Than 100 Employees

Investors Active in South Korea

Boryung, originally involved in pharmaceutical wholesale, transitioned into pharmaceutical manufacturing in 1963. Instead of simply being a drug manufacturer, the company decided to invest in the development of essential medicines for patients. This strategic shift paved the way for sustained growth in the pharmaceutical industry. Notably, in March 2011, Boryung achieved a significant milestone by introducing "Kanarb," the first ARB (Angiotensin II Receptor Blocker) antihypertensive medication in South Korea.

Looking ahead, in April 2022, Boryung is set to host the inaugural Care in Space (CIS) Challenge. This initiative demonstrates the company's commitment to exploring new horizons and aligns with its mission to become an indispensable contributor to human health in the era of space exploration. By embarking on this challenge, Boryung aims to discover fresh opportunities that can further its role in advancing human health, especially as technological advancements open up new frontiers.

Seoul

Seoul-t'ukpyolsi

South Korea

Asia

Boryung Pharmaceutical

Drug maker Boryung targets its highest-ever sales in 2024

Boryung, Axiom Space launch joint venture in Korea

The 10 Biggest Rounds Of August: Huge Deals Abound As Redwood Materials And Peregrine Energy Lead Way

The Week’s 10 Biggest Funding Rounds: Axiom Space Rockets To Top Spot In Out-Of-This-World Week

Saudi Arabia Investment Is Increasing In US-Based Startups

Boryung Decides to Invest US$50mn in Axiom Space of the U.S.

Ukraine

Europe

Boryung Corporation produces and sells pharmaceutical products in South Korea. The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's. It also exports its products to approximately 50 countries on 6 continents, including Japan, China, the Southeast Asia, the Middle East, Europe, South America, and Africa. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is based in Seoul, South Korea.

Boryung Corporation

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 14, 2024 9:54 PM	0b06800e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 29, 2024 5:10 PM	21d7bb49
crunchbase profile	general	Oct 30, 2024 8:41 AM	f5644ffa
li profile	general	Aug 14, 2024 9:54 PM	f8eee06e
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	690c5241
peers	general	Aug 14, 2024 9:54 PM	8c8836a8
news basic	general	Aug 14, 2024 9:54 PM	a6f6e946
bundesanzeiger	filings
financials download nd	financials
private financials	financials

KR:CO:BORYUNG

Boryung

Last Close

10,140.00

25/11 06:30

Market Cap

687.64B

Beta: -

Volume Today

142.03K

Avg: -